The crystal-chemistry of 13 elbaite-schorl tourmaline crystals from the Cruzeiro pegmatite (Minas Gerais, Brazil) was studied with a multi-analytical approach (SREF, EMPA, SIMS, MS). Effective cation radii at the Y and Z sites and site populations were refined by a minimization procedure. The results indicate that the crystals belong to the alkali group. Elbaite crystals are O2--free at the W and V sites and show OH content at the O2 site (up to 0.2 apfu). Conversely, schorl crystals always show O2- at the W site. The main substitutional mechanism is the dehydroxylation type: Fe-Y(2+) + Fe-Y(3+) + O-w -> Li-Y + Al-Y + (W)(OH+F). The T site is characterized by Si-T -> Al-T substitution. < X-O > is linearly correlated with vacancy content in crystals with (OH + F) ! 4, whereas it is almost constant in crystals with OH at the 02 position. Along the series, < Y-O > is inversely correlated with Al-Y. The Z site is almost fully occupied by R3+ (with Al-Z largely dominant) and the Fe-Z(tot) <-> Al-Z substitution explains the inverse correlation of < Z-O > with Al-Z. In the elbaite compositional range, lattice parameters are functions of < Y-O >, whereas in the schorl range they are essentially functions of < Z-O >. Alone, the whole elbaite-schorl series, both chemical substitutions and size increase of Y are far larger than those of Z. In spite of this, lattice parameters increase with < Y-O > as much as with < Z-O >. This is due to the role of the [ZO(6)] polyhedra, which extend along a and c to form the skeleton of the tourmaline structure. Therefore, any change in the size of Z leads to a change in the whole structure
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.